Quick Answer: Individuals with personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, known hypersensitivity to these medications, pregnant or breastfeeding women, and those with certain medical conditions should not take weight loss injections without careful medical evaluation
Below 1 mg is supported by acute Phase 1 readings in lean Asian participants and real-world reports, but not by a chronic dosing trial
Retatrutide is an injection administered weekly, which others may find simpler than daily pills
The whole purpose to lose weight is to prevent these kinds of health issues so it should be covered under UHC benefits
Reconstituted tirzepatide is a clear, colorless liquid
Its ability to promote weight loss, coupled with its ease of administration, makes it an attractive choice for those seeking a powerful weight loss solution